No Picture
Trading Ideas

JPMorgan: These 3 Stocks Are Well-Positioned to Benefit from 5G Ramp

Investment bank JPMorgan has been looking into the advent of 5G, and pointing out possible paths that the new technology will take as it makes inroads to the digital ecosystem. The most obvious point, of course, is that by the end of this year all of the major mobile providers will have rolled out nationwide 5G networks. That shift has already begun.What is equally important, but less obvious, is that paths toward monetization are not completely clear. JPMorgan does not expect digital customers to pay for 5G specifically in selecting new plans. Customer choice of provider may hinge on the …read more […]

No Picture
Trading Ideas

Bayer asks California court to reverse $86 mln Roundup cancer verdict

Bayer AG has asked a California appeals court to overturn an $86 million verdict that found it was responsible for a couple’s cancer caused by its glyphosate-based weed killer Roundup. In a Friday night filing with the California First District Court of Appeal in San Francisco, the company said the jury’s verdict could not be reconciled with either the law or sound science. The May verdict by a California jury drew nationwide attention for its massive damages, with the jury awarding more than $2 billion to Alberta and Alva Pilliod, who sprayed Roundup on their property for more …read more […]

No Picture
Trading Ideas

Roche, Lilly drugs fail to halt gene-driven Alzheimer's disease

Experimental drugs from Roche and Eli Lilly failed to halt Alzheimer’s disease in their latest test, the companies said on Monday, in a blow to people whose genes make them particularly vulnerable to the illness. Pursuit of an Alzheimer’s remedy, which would inevitably reap drugmakers billions of dollars, has been marked by more than 100 failures, although researchers still hope to tame a condition that affects nearly 6 million Americans, more than 40 million people worldwide, and which is growing more prevalent. The study of Roche’s gantenerumab and Eli Lilly’s solanezumab spearheaded by Washington University in St. Louis …read more […]

No Picture
Trading Ideas

Xerox Increases Offer Price for HP to $24 a Share

(Bloomberg) — Xerox Holdings Corp. increased its offer price for HP Inc. to $24 a share, boosting the bid by $2 a share in an effort to win control of the computer hardware maker, which has previously refused to engage in takeover talks because it said the offer was too low.Xerox said in a statement Monday it plans to launch a tender offer “on or around March 2” comprised of $18.40 in cash and 0.149 Xerox shares for each HP share. The offer won’t be subject to any conditions related to financing or due diligence. The offer represents a 41% …read more […]

No Picture
Trading Ideas

3 “Strong Buy” Healthcare Stocks With Triple-Digit Upside

To buy or not to buy, that’s the question. For even the most seasoned Wall Street observers, determining the ideal time to pull the trigger on a particular ticker can be a challenge. These decisions involve considering what type of gains are expected, more consistent growth achieved over the long haul or rapid upward climbs.More risk-tolerant investors are often drawn to the latter, enticed by the possibly of sky-high returns delivered at the drop of a hat. So, where can these stocks with huge upside potential be found? The healthcare sector. Its nature positions many companies to see their share …read more […]